Comparing the FGFR2 gene expression in the breast cancer subtypes, the mRNA expression was highest in luminal-A and luminal-B tumours, slightly lower in basal-like tumours, and significantly lower in HER2-enriched tumours (Figure 3A). This evidence concerns the gene ERBB2 and breast cancer.